All posts in Biologics
Senators press Medtronic for device info
WASHINGTON – Three U.S. senators have asked Fridley-based Medtronic Inc. to supply detailed information about how the company keeps track of its medical devices after they go to market. In a six-page letter that strikes an investigational tone, Sens. Charles …
Baxter to acquire Synovis
Baxter International Inc. (NYSE:BAX) and Synovis Life Technologies, Inc. (NASDAQ:SYNO) today announced a definitive agreement for Baxter to acquire Synovis, a leading provider of biological and mechanical products
Update: Two ex-Synthes executives, Michael Huggins and Thomas Higgins, get 9 months in prison
UPDATE 3 p.m.: At about 2:45 p.m., Brent Gurney, the attorney for Richard Bohner, collapsed while standing at a lectern discussing his client with Judge Davis. Gurney was
Ex-Synthes Executives Scheduled to be Sentenced Today
One doctor employed by the medical device manufacturer Synthes, Inc., called it "human experimentation." That doctor was fired. Four of the company executives who stuck around for the illegal
Third genetic link to osteoarthritis discovered
New gene identified that affects levels of pain in osteoarthritis following use of 1000 Genomes study data
Researchers have today revealed a new gene associated with osteoarthritis. This is
ORTHOCON Announces Signing of Exclusive, Worldwide License Agreement With Bezwada Biomedical
IRVINGTON, N.Y., Aug. 31, 2011 /PRNewswire/ -- ORTHOCON, Inc., a privately-held therapeutic device company, today announced the signing of an exclusive, worldwide license agreement with Bezwada Biomedical to develop and
Spinal Restoration, Inc. Receives Patent Allowance for the Biostat® System
AUSTIN, Texas--(BUSINESS WIRE)--Spinal Restoration, Inc. announced today that it has received a Notice of Allowance from the U.S. Patent and Trademark Office for claims concerning the delivery
Ceremed sells Ostene to Baxter
Ceremed, Inc. (Los Angeles) announced today that it has entered into a definitive agreement to sell its Ostene® brand bone hemostasis product line to Baxter International Inc. The
First Minimally-Invasive Procedure Performed in Mesoblast’s Phase 2 Stem Cell Trial for Lumbar Disc Repair
MELBOURNE, Australia, Aug. 22, 2011 /PRNewswire/ -- Regenerative medicine company, Mesoblast Limited (ASX:MSB), today announced that the first minimally-invasive lumbar disc procedure had been successfully performed in the Phase 2
NovaBone Announces New Moldable Bone Graft
JACKSONVILLE, Fla.--(BUSINESS WIRE)--NovaBone Products announces the introduction of MacroPor-Si+ to its portfolio of biologically active bone graft substitutes. NovaBone Products develops bone graft substitutes based on advancements in
Bacterin Secures $15 Million Credit Facility with MidCap Financial and Silicon Valley Bank
BELGRADE, Mont., Aug. 1, 2011 /PRNewswire via COMTEX/ -- Bacterin International Holdings, Inc.BONE -3.78% , a leader in the development of revolutionary bone graft material and anti-infective coatings
RTI Biologics Announces 2011 Second Quarter Results
ALACHUA, Fla.--(BUSINESS WIRE)--RTI Biologics Inc. (RTI) (Nasdaq: RTIX), a leading provider of orthopedic and other biologic implants, reported operating results for the second quarter of 2011
Histogenics Reports Positive Phase 2 Data for NeoCart Autologous Cartilage Tissue Implant for the Treatment of Knee Cartilage Injury
WALTHAM, Mass.--(BUSINESS WIRE)--Histogenics Corporation, a privately held regenerative medicine company, today announced the presentation of positive Phase 2 data for the NeoCart Autologous Cartilage Tissue Implant (ACTI).
Medtronic deals with questions of biased research
In a strong course of action, The Spine Journal recently dedicated its entire June issue to a review of recombinant bone morphogenetic protein-2 (rhBMP-2)-a synthetic bone growth product-and